AAREY DRUGS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -14.98% YoY .
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -42.25 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
AAREY DRUGS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524412|NSE : AAREYDRUGS]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹419 Cr | ₹493 Cr | ₹348 Cr | ₹300 Cr | ₹355 Cr |
| Expenses | ₹411 Cr | ₹481 Cr | ₹344 Cr | ₹297 Cr | ₹347 Cr |
| Operating Profit (Excl OI) | ₹7.72 Cr | ₹11 Cr | ₹4.65 Cr | ₹3.23 Cr | ₹7.89 Cr |
| Other Income | ₹2.73 Cr | ₹2.67 Cr | ₹7.02 Cr | ₹6.69 Cr | ₹4.34 Cr |
| Interest | ₹2.87 Cr | ₹2.04 Cr | ₹2.44 Cr | ₹1.79 Cr | ₹2.23 Cr |
| Depreciation | ₹1.57 Cr | ₹1.99 Cr | ₹0.92 Cr | ₹0.89 Cr | ₹1.01 Cr |
| Profit Before Tax | ₹6.01 Cr | ₹10 Cr | ₹8.30 Cr | ₹7.24 Cr | ₹8.99 Cr |
| Profit After Tax | ₹3.77 Cr | ₹6.56 Cr | ₹6.51 Cr | ₹5.79 Cr | ₹6.54 Cr |
| Consolidated Net Profit | ₹3.77 Cr | ₹6.56 Cr | ₹6.51 Cr | ₹5.79 Cr | ₹6.54 Cr |
| Earnings Per Share (Rs) | ₹1.49 | ₹2.58 | ₹2.79 | ₹2.48 | ₹2.80 |
| PAT Margin (%) | 0.90 | 1.33 | 1.87 | 1.93 | 1.84 |
| ROE(%) | 3.33 | 6.31 | 6.98 | 6.65 | 8.07 |
| ROCE(%) | 6.27 | 9.87 | 9.46 | 8.48 | 12.05 |
| Total Debt/Equity(x) | 0.33 | 0.13 | 0.19 | 0.20 | 0.19 |
Key Financials |
||
| Market Cap | : | ₹ 150.2 Cr |
| Revenue (TTM) | : | ₹ 343.4 Cr |
| Net Profit(TTM) | : | ₹ 3.8 Cr |
| EPS (TTM) | : | ₹ 1.3 |
| P/E (TTM) | : | 39.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AAREY DRUGS & PHARMACEUTICALS | 13.7% | 18.2% | 79.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
| CIPLA | 4.5% | -3.1% | 52.8% |
| DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
| ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
| DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
| MANKIND PHARMA | 2.7% | 12.4% | NA |
| TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
| LUPIN | 3.1% | -1.1% | 127.4% |
AAREY DRUGS & PHARMACEUTICALS Revenues
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -14.98 % |
| 5 Yr CAGR | 4.25 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹419 Cr | -14.98 | |
| Mar2022 | ₹493 Cr | 41.43 | |
| Mar2021 | ₹348 Cr | 16.10 | |
| Mar2020 | ₹300 Cr | -15.40 | |
| Mar2019 | ₹355 Cr | - | |
AAREY DRUGS & PHARMACEUTICALS Operating Profit
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -32.25 % |
| 5 Yr CAGR | -0.53 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹7.72 Cr | -32.25 | |
| Mar2022 | ₹11 Cr | 145.02 | |
| Mar2021 | ₹4.65 Cr | 43.90 | |
| Mar2020 | ₹3.23 Cr | -59.02 | |
| Mar2019 | ₹7.89 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -20.35 % |
| 5 Yr CAGR | -4.59 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 1.84% | -20.35 | |
| Mar2022 | 2.31% | 73.68 | |
| Mar2021 | 1.33% | 23.15 | |
| Mar2020 | 1.08% | -51.35 | |
| Mar2019 | 2.22% | - | |
AAREY DRUGS & PHARMACEUTICALS Profit After Tax
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -42.47 % |
| 5 Yr CAGR | -12.87 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹3.77 Cr | -42.47 | |
| Mar2022 | ₹6.56 Cr | 0.63 | |
| Mar2021 | ₹6.51 Cr | 12.43 | |
| Mar2020 | ₹5.79 Cr | -11.43 | |
| Mar2019 | ₹6.54 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -32.33 % |
| 5 Yr CAGR | -16.37 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 0.9 % | -32.33 | |
| Mar2022 | 1.33 % | -28.88 | |
| Mar2021 | 1.87 % | -3.11 | |
| Mar2020 | 1.93 % | 4.89 | |
| Mar2019 | 1.84 % | - | |
AAREY DRUGS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -42.25 % |
| 5 Yr CAGR | -14.59 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹1.49 | -42.25 | |
| Mar2022 | ₹2.58 | -7.53 | |
| Mar2021 | ₹2.79 | 12.50 | |
| Mar2020 | ₹2.48 | -11.43 | |
| Mar2019 | ₹2.80 | - | |
AAREY DRUGS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -36.47 % |
| 5 Yr CAGR | -15.07 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 6.27% | -36.47 | |
| Mar2022 | 9.87% | 4.33 | |
| Mar2021 | 9.46% | 11.56 | |
| Mar2020 | 8.48% | -29.63 | |
| Mar2019 | 12.05% | - | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹53.5 |
| Current MarketCap | : | ₹ 150.2 Cr |
| Updated EOD on | : | Apr 25,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | 13.7% |
18.2% |
79.5% |
| SENSEX | 1.3% |
2.6% |
24% |
AAREY DRUGS & PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about AAREY DRUGS & PHARMACEUTICALS Financials
How the annual revenues of AAREY DRUGS & PHARMACEUTICALS have changed ?
The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -14.98% YoY .
How the Earnings per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -42.25 % YoY .
Check out Intrinsic Value of Peers of AAREY DRUGS & PHARMACEUTICALS
Compare Stock Analytics of Peers of AAREY DRUGS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
